Bariatric surgery: an IDF statement for obese Type 2 diabetes

Abstract

Diabet. Med. 28, 628–642 (2011) The International Diabetes Federation Taskforce on Epidemiology and Prevention of Diabetes convened a consensus working group of diabetologists, endocrinologists, surgeons and public health experts to review the appropriate role of surgery and other gastrointestinal interventions in the treatment and prevention of Type 2 diabetes. The specific goals were: to develop practical recommendations for clinicians on patient selection; to identify barriers to surgical access and suggest interventions for health policy changes that ensure equitable access to surgery when indicated; and to identify priorities for research. Bariatric surgery can significantly improve glycaemic control in severely obese patients with Type 2 diabetes. It is an effective, safe and cost‐effective therapy for obese Type 2 diabetes. Surgery can be considered an appropriate treatment for people with Type 2 diabetes and obesity not achieving recommended treatment targets with medical therapies, especially in the presence of other major co‐morbidities. The procedures must be performed within accepted guidelines and require appropriate multidisciplinary assessment for the procedure, comprehensive patient education and ongoing care, as well as safe and standardized surgical procedures. National guidelines for bariatric surgery need to be developed for people with Type 2 diabetes and a BMI of 35 kg/m 2 or more.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 81

1. 1.

   Unwin N, Gan D, Whiting D. The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract. 2010;87:2-3.

   Not in our library10.1016/j.diabres.2009.11.006

2. 2.

   Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.

   Not in our library10.1016/j.diabres.2009.10.007

3. 3.

   Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-880.

   Not in our library10.1038/nature05487

4. 4.

   Kumanyika SK, Obarzanek E, Stettler N, Bell R, Field AE, Fortmann SP, et al. Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the Expert Panel on Population and Prevention Science). Circulation. 2008;118:428-464.

   Not in our library10.1161/circulationaha.108.189702

5. 5.

   Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752.

   Not in our library10.1056/nejmoa066254

6. 6.

   Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-256.

   Not in our library10.1016/j.amjmed.2008.09.041

7. 7.

   Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.

   Not in our library10.1056/nejmoa035622

8. 8.

   Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. J Am Med Assoc. 2004;292:1724-1737.

   Not in our library10.1001/jama.292.14.1724

9. 9.

   Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761.

   Not in our library10.1056/nejmoa066603

10. 10.

    Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N, et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond). 2007;31:569-577.

    Not in our library10.1038/sj.ijo.0803560

11. 11.

    Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract. 2008;14:S1-S83.

    Not in our library10.4158/ep.14.s1.1

12. 12.

    Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. 2006.

    Not in our library

13. 13.

    Lakdawala M, Bhasker A. Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population: 9–10 August 2008, Trivandrum, India. Obes Surg. 2010;20:929-936.

    Not in our library10.1007/s11695-010-0162-7

14. 14.

    Rubino F, Kaplan LM, Schauer PR, Cummings DE. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251:399-405.

    Not in our library10.1097/sla.0b013e3181be34e7

15. 15.

    Zimmet P, Campbell LV, Toomath R, Twigg S, Wittert G, Proietto J. Bariatric surgery to treat severely obese patientswith type 2 diabetes: a consensus statement. Obes Res Clin Pract. 2011.

    Not in our library10.1016/j.orcp.2010.11.005

16. 16.

    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009;52:17-30.

    Not in our library10.1007/s00125-008-1157-y

17. 17.

    Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481-486.

    Not in our library10.7326/0003-4819-122-7-199504010-00001

18. 18.

    Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961-969.

    Not in our library10.2337/diacare.17.9.961

19. 19.

    Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Prev Med. 2007;45:348-352.

    Not in our library10.1016/j.ypmed.2007.07.020

20. 20.

    Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30:1374-1383.

    Not in our library10.2337/dc07-0048

21. 21.

    Norris SL, Zhang X, Avenell A, Gregg E, Brown TJ, Schmid CH, et al. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev. 2005;CD004095.

    Not in our library10.1002/14651858.cd004095.pub2

22. 22.

    Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;CD004096.

    Not in our library10.1002/14651858.cd004096.pub2

23. 23.

    Farooqi IS, O'Rahilly S. Genetic factors in human obesity. Obes Rev. 2007;8:S37-S40.

    Not in our library10.1111/j.1467-789x.2007.00315.x

24. 24.

    Swinburn B, Egger G. Prevention of type 2 diabetes. Prevention needs to reduce obesogenic environments. Br Med J. 2001;323:997.

    Not in our library

25. 25.

    Schwartz MW, Porte D. Diabetes, obesity, and the brain. Science. 2005;307:375-379.

    Not in our library10.1126/science.1104344

26. 26.

    Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621-628.

    Not in our library10.1056/nejm199503093321001

27. 27.

    Foo J, Toomath R, Wickremesekera SK, Bann S, Stubbs R. Bariatric surgery: a dilemma for the health system? N Z Med J. 2010;123:12-14.

    Not in our library

28. 28.

    Dixon JB. Referral for a bariatric surgical consultation: it is time to set a standard of care. Obes Surg. 2009;19:641-644.

    Not in our library10.1007/s11695-008-9765-7

29. 29.

    Tripathy D, Chavez AO. Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus. Curr Diab Rep. 2010;10:184-191.

    Not in our library10.1007/s11892-010-0115-5

30. 30.

    Overview of 6 years’ therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group, study 16. Diabetes. 1995;44:1249-1258.

    Not in our library

31. 31.

    Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM, et al. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care. 2010;33:983-990.

    Not in our library10.2337/dc09-1278

32. 32.

    Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359:1565-1576.

    Not in our library10.1056/nejmoa0806359

33. 33.

    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193-203.

    Not in our library10.2337/dc08-9025

34. 34.

    Trompet S, de Craen AJ, Mooijaart S, Stott DJ, Ford I, Sattar N, et al. High innate production capacity of proinflammatory cytokines increases risk for death from cancer: results of the PROSPER Study. Clin Cancer Res. 2009;15:7744-7748.

    Not in our library10.1158/1078-0432.ccr-09-2152

35. 35.

    Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia. 2002;45:S23-S28.

    Not in our library10.1007/s00125-002-0863-0

36. 36.

    Roman G, Hancu N. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes. Horm Metab Res. 2009;41:116-122.

    Not in our library10.1055/s-0028-1128144

37. 37.

    Bailey CJ, Del Prato S, Eddy D, Zinman B. Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control. Int J Clin Pract. 2005;59:1309-1316.

    Not in our library10.1111/j.1742-1241.2005.00675.x

38. 38.

    Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev. 2009;CD003641.

    Not in our library10.1002/14651858.cd003641.pub3

39. 39.

    Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg. 2001;25:527-531.

    Not in our library10.1007/s002680020348

40. 40.

    Rubino F, R'Bibo SL, del Genio F, Mazumdar M, McGraw TE. Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol. 2010;6:102-109.

    Not in our library10.1038/nrendo.2009.268

Cited by papers we hold 1

• Diabetes and Weight in Comparative Studies of Bariatric Surgery vs Conventional Medical Therapy: A Systematic Review and Meta-Analysis · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.